PTH and hyperparathyroidism: In a randomized, double-blind, crossover study including 15 MEN1 patients with hyperparathyroidism (216), cinacalcet led to normalization of serum calcium, significant increase in serum phosphate, and reduction of PTH levels in all patients after 3 months of therapy.